Back

Cardiac reverse remodeling and SGLT2ii: insight from hemodynamic forces analysis

11 May 2024 (13:00 - 13:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - pathophysiology and mechanisms 7 Ventricular Remodelling HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Silvia Prosperi

Sapienza University of Rome, Rome (Italy)

4 More presentations in this session

Presentation thumbnail
Prognostic implications of adaptive and maladaptive right ventricular hypertrophy in patients with heart failure: a prospective observational cohort study
Doctor L. Dinc Asarcikli (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Predictors of early left ventricular reverse remodelling and prognosis in new-onset heart failure of non-ischemic origin
Doctor T. Hnat (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Dapagliflozin's influence on cardiac remodeling in chronic heart failure patients
Doctor A. Ribeiro Teixeira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Safety and tolerability of diuretics withdrawal in heart failure with reduced ejection fraction. The REDICAE trial
Mr J. Torres Zamudio (Cordoba, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - pathophysiology and mechanisms 7

The Event

Event poster

Heart Failure 2024

11 May 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac reverse remodeling after SGLT2 inhibitor therapy: exploring beyond sex differences
thumbnail
Congress Presentation
Use of SGLT2 inhibitors in real life: predicting left ventricular reverse remodelling.
thumbnail
Congress Presentation
The impact of sodium glucose transporter 2 inhibitors on cardiac remodeling in a large cohort of unselected patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources